Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

At the conclusion of the Case Studies in IO: A Closer Look at Care Delivery education initiative participants should be able to: Assess current vs. best practices concerning coordination and communication with the multidisciplinary cancer care team to optimize integration of cancer immunotherapies. Evaluate tools and resources for monitoring and managing immune-related adverse events associated …
Temple University Hospital, Temple Cancer Program Philadelphia, Pennsylvania Creating Transparency with an Electronic Dosimetry Whiteboard Delays in completion of treatment plans were leading to decreased patient satisfaction, patient care delays, lowered employee morale, and potential lost revenue. Analysis showed improvement was needed in communication between staff members and timely completion …
Educate: Health Literacy Patient-Centered Provider Program Provided by Lilly Oncology The “Health Literacy and Clear Communication Patient-Centered Provider Workshop” focuses on how clear communication may be used to support health literacy initiatives. Data and real-world case studies are used to present the effects of low literacy on costs of care, quality of and access to care, and health …
We support all healthcare and long-term care employers requiring their workers to be vaccinated against COVID-19.
Jeffrey Kendall, PsyD, LP, shares useful tips and resources for compassionate communication with patients during the COVID-19 pandemic.
January 11, 2024 • 5:30 pm to 8:00 pm Ralph’s on the Park Explore the forefront of medical advancements in oncology and hematology with engaging talks by talented fellows. Topics will range from the latest breakthroughs in oncology to innovative approaches in medical education. Please note that individuals employed by pharmaceutical/ device manufacturers (including MSLs), consulting, or …
Electronic Health Records (EHR) Integrations for Biomarker Testing: Roadmap The EHR Integrations for Biomarker Testing Roadmap is an interactive learning tool that can help multidisciplinary cancer care teams acquire insights on initiating, preparing for, implementing, and evaluating EHR biomarker testing integrations. This roadmap equips multidisciplinary cancer care teams with essential information …
CANCER BUZZ previews the sessions, people and topics of this week’s ACCC 40th National Oncology Conference. We interview Kathy Oubre, MS, CEO of the Pontchartrain Canter Center, about helping patients overcome access barriers to biomarker testing.
To help facilitate the education and training that new treatment options often require, ACCC has created the Oncology Practice Transformation and Integration Center (OPTIC).
ACCC 41st National Oncology Conference October 9-11, 2024 Hilton Minneapolis, Minnesota With a theme of Realizing Innovation, the ACCC 41st National Oncology Conference will feature education and resources to help participants affect positive change at their cancer programs and practices. Learn from the experiences of the 2024 ACCC Innovator Award winners, network with colleagues on common challenges …
Nurses at this NCI-designated Comprehensive Cancer Center piloted an evidence-based project that engaged an immersive virtual reality experience to reduce fear and anxiety among patients with cancer receiving chemotherapy treatment.
Grand Valley Oncology, a freestanding cancer care facility wholly owned by Community Hospital, provides full spectrum outpatient medical and radiation oncology services as well as robust survivorship and integrative therapies programs.
Columbia St. Mark's Hospital Salt Lake City, Utah Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Columbia St. Mark's Hospital Salt Lake City, Utah Building a Cancer Support Center …
14 accc-cancer.org | Vol. 37, No. 5, 2022 | OI Approved Drugs • On June 24 the U.S. Food and Drug Administration (FDA) approved Breyanzi® (lisocabtagene maraleucel) (Bristol Myers Squibb, bms.com) for adult patients with large B-cell lymphoma who have refractory disease to first-line chemo- immunotherapy or relapse within 12 months of first-line chemo- immunotherapy or who have refractory …
Pharmaceutical Update Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Pharmaceutical Update To cite this article: (1996) Pharmaceutical Update, Oncology Issues, 11:1, 12-13, DOI: …
MA02-Action
An Interview with ACCC President Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 An Interview with ACCC President Robert L. White To cite this article: Robert L. White (1998) An …
MA2012-Spotlight
MA05-Tools
MA11-Quincy-Medical-Group